The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.

Psaty, B M; Heckbert, S R; Atkins, D; Lemaitre, R; Koepsell, T D; Wahl, P W; Siscovick, D S; Wagner, E H

Psaty, B M; Heckbert, S R; Atkins, D; Lemaitre, R; Koepsell, T D; Wahl, P W; Siscovick, D S; Wagner, E H.

Affiliation

Psaty BM; Department of Medicine, University of Washington, Seattle.

Arch Intern Med ; 154(12): 1333-9, 1994 Jun 27.

Article in En | MEDLINE | ID: mdl-8002685

Subject(s)

Estrogens/therapeutic use; Medroxyprogesterone/therapeutic use; Myocardial Infarction/epidemiology; Postmenopause; Aged; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Logistic Models; Risk Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Postmenopause / Estrogens / Medroxyprogesterone / Myocardial Infarction Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: Arch Intern Med Year: 1994 Type: Article

Search on Google

XML

PubMed Links